Eikon Therapeutics to Present New Phase 2 Data on EIK1001 in First-Line Non-Small Cell Lung Cancer at ESMO 2025
Presentation highlights novel TLR7/8 co-agonist in combination with pembrolizumab and chemotherapy in late-stage NSCLC Additional clinical-stage programs, including... Read more.
Ferguson Files Definitive Proxy Materials and Annual Report
NEWPORT NEWS, Va.–(BUSINESS WIRE)–On October 15, 2025, Ferguson Enterprises Inc. (the “Company”) filed a Definitive Proxy Statement, Definitive... Read more.
Prolink Appoints Vanessa Janus as Chief Workforce Solutions Officer, Driving Strategic Growth and Advancing Healthcare Talent Solutions
CINCINNATI–(BUSINESS WIRE)–Prolink, a premier workforce solutions firm, is pleased to announce the appointment of Vanessa Janus as Chief Workforce Solutions... Read more.
IonQ to Report Third Quarter 2025 Financial Results on November 5, 2025
COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), a leading quantum company, today announced that it will release its financial results for the quarter... Read more.
SkyWater Technology to Announce Third Quarter Financial Results on November 5, 2025
BLOOMINGTON, Minn.–(BUSINESS WIRE)–SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced that it will report... Read more.
Nextracker and T1 Energy Sign Multi-Year Agreement for Supply of Advanced Solar Panel Frames Engineered and Made in the USA
The framework agreement targets multi-gigawatt solar module frame supply over several years valued at over $75 million FREMONT, Calif. & AUSTIN, Texas–(BUSINESS... Read more.
Advyzon Expands Its All-In-One Platform With Financial Planning, Adding Kevin Hughes to Head Efforts and Tony Leal as a Strategic Advisor
Comprehensive wealthtech platform plans to launch new capability in 2026 CHICAGO–(BUSINESS WIRE)–#CRM—Advyzon, a comprehensive technology platform... Read more.
Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection
DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment... Read more.
NGL Energy Partners Announces Earnings Call
TULSA, Okla.–(BUSINESS WIRE)–NGL Energy Partners LP (NYSE: NGL) announced today that it plans to issue its quarter ended September 30, 2025, earnings... Read more.
CHAOS Industries and Forterra Announce Partnership to Deliver Integrated Autonomous Counter‑UAS Capabilities
Joint offering delivers scalable, field-proven counter‑UAS capability for defense and homeland security missions LOS ANGELES & CLARKSBURG, Md.–(BUSINESS... Read more.